AAPG – ascentage pharma group international - american depository shares (US:NASDAQ)
Stock Stats
News
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.